Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1991-11-12
1994-07-12
Hill, Jr., Robert J.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352401, 43524023, 435240243, 435 7021, 435180, 435181, 514 2, 530300, 530350, C12N 500, C12N 1108, A61K 3702, A61K 3700
Patent
active
053288408
ABSTRACT:
The present invention provides new compounds and methods for promoting platelet aggregation, and controlling bleeding. The present invention is based on the surprising discovery that erythrocytes conjugated to certain peptides and polypeptides containing an R-G-D (Arg-Gly-Asp) sequence (collectively termed herein "RGD peptides") according to the invention, selectively bind to activated platelets but not to unactivated platelets. In recognition of the dual nature of the derivatized erythrocytes, they are termed herein "thrombo-erythrocytes". The thrombo-erythrocytes have no significant change in their rheological properties. In a preferred aspect, the thrombo-erythrocytes have the majority of RGD peptide cross-linked specifically to glycophorin A and glycophorin B on the surface of the erythrocyte. In the thrombo-erythrocytes of the invention, preferably, the N-terminal Arg of the R-G-D sequence should be spaced within 9-50 Angstroms, more preferably 10-40 Angstroms, and most preferably 11-25 Angstroms, from the erythrocyte protein to which the RGD peptide is conjugated. The invention is further directed to erthrocytes modified by replacement of their intracellular contents with a composition comprising a label or agent. Such modified erythrocytes are termed herein "carrier erythrocytes". The carrier erythrocytes have use in delivery of such labels or biologically active agents to specific tissues by conjugation to a targeting agent.
REFERENCES:
patent: 4244946 (1981-01-01), Rivier et al.
patent: 4305872 (1981-12-01), Johnston et al.
patent: 4316891 (1982-02-01), Guillemin et al.
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4988621 (1991-01-01), Ruoslahti et al.
Caulfield et al., 1984, "The 64-kilodalton membrane protein of Bacillus subtilis is also present as a multiprotein complex on membrane-free ribosomes," Proc. Natl. Acad. Sci. USA 81:7772-7776.
Coller et al., 1990, "Thromboerythrocytes: preliminary in vitro attempts to develop a semi-artificial, autologous platelet (P) substitute," Circulation, Suppl. III., 82(4), Abstract 2377.
Coller, 1980 "Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia," Blood 55:169-178.
Cumber et al., 1985, "Preparation of antibody-toxin conjugates," Meth. Enzymol. 112:207-225.
Hamada and Tsuruo, 1987, "Determination of membrane antigens by a covalent crosslinking method with monoclonal antibodies," Anal. Biochem. 160:483-488.
Lerner et al., 1981, "Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles," Proc. Natl. Acad. Sci. USA 78:3403-3407.
Merrifield, 1964, "Solid phase peptide synthesis. II. The synthesis of bradykinin," J. Am. Chem. Soc. 83:304-305.
Merrifield, 1964, "Solid phase synthesis. I. The synthesis of a tetrapeptide," J. Am. Chem. Soc. 85:2149-2154.
Pilch and Czech, 1979, "Interaction of cross-linking agents with the insulin effector system of isolated fat cells," J. Biol. Chem. 254:3375-3381.
Plow et al., 1987, "Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets", Blood 70:110-115.
Sun et al., 1974, "Topography of ribosomal proteins of the Escherichia coli 30S subunit as studied with the reversible cross-linking reagent methyl 4-mercaptobutyrimidate," Biochemistry 13:2334-2340.
Vale et al., 1981, "Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of croticotropin and .beta.-endorphin," Science 213:1394-1397.
Yoshitake et al., 1982, "Mild and efficient conjugation of rabbit Fab' and horseradish peroxidase using a maleimide compound and its use for enzyme immunoassay," J. Biochem. 92:1413-1424.
Youle and Neville, 1980, "Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin," Proc. Natl. Acad. Sci. USA 77:5483-5486.
1984, "Red Blood Cells as Carriers for Drugs. A Method for Disseminating Chemotherapeutics, Hormones, Enzymes and Other Therapeutic Agents via the Circulatory System," De Loach and Sprangel, eds., First International Conference on Red Blood Cell Carriers at the Rockefeller Foundation Bellagio Study and Conference Center, Bellagio (Italy), Feb. 27-Mar. 2, 1984, Table of Contents.
1987, Red Blood Cells as Carriers for Drugs. Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, Table of Contents and Forward, pp. v-x.
Alpar and Irwin, 1987, "Some unique applications of erythrocytes as carrier systems," in Red Blood Cells as Carriers for Drugs. Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, pp. 1-9.
DeLoach et al., 1977, "Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes," Biochim. et Biophys. Acta 496:507-515.
DeLoach et al., 1985, "Carrier erythrocytes: a prospectus for the future," in Red Blood Cells as Carriers for Drugs. A Method for Disseminating Chemotherapeutics, Hormones, Enzymes and Other Therapeutic Agents via the Circulatory System, DeLoach and Sprangel, eds., First International Conference on Red Blood Cell Carriers at the Rockefeller Foundation Bellagio Study and Conference Center, Bellagio (Italy), Feb. 27-Mar. 2, 1984, Karger, Basel, pp. 157-159.
DeLoach et al., 1987, "Erythrocytes as carriers of mycotoxins for targeting to the reticuloendothelial system," in Red Blood Cells as Carriers for Drugs, Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, pp. 191-197.
DeLoach and Corrier, 1988, "Subcutaneous administration of carrier erythrocytes: slow release of entrapped agent," Biotechnol. Appl. Biochem. 10:359-364.
Eichler et al., 1987, "In vitro drug release from human carrier erythrocytes," in Red Blood Cells as Carriers for Drugs. Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, pp. 11-15.
Kruse et al., 1987, "Methotrexate loaded erythrocyte carriers: optimizing their formation, their characterization, and their pharmacological efficacy in treating hepatoma 129 ascites tumors in mice," in Red Blood Cells as Carriers for Drugs. Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, pp. 137-144.
Makler et al., 1987, "Erythrocyte membrane changes associated with ligands which bind to the glycophorins," in Red Blood Cells as Carriers for Drugs. Potential Therapeutic Applications, Ropars et al., eds., Pergamon Press, Oxford, Great Britain, pp. 251-260.
Mishra et al., 1985, "Encapsulation and targeting of drugs in electrically hemolysed red cells," in Red Blood Cells as Carriers for Drugs. A Method for Disseminating Chemotherapeutics, Hormones, Enzymes and Other Therapeutic Agents via the Circulatory System, DeLoach and Sprangel, eds., First International Conference on Red Blood Cell Carriers at the Rockefeller Foundation Bellagio Study and Conference Center, Bellagio (Italy), Feb. 27-Mar. 2, 1984, Karger, Basel, pp. 115-126.
Ropars et al., 1985, "Resealed red blood cells as a new blood transfusion product," in Red Blood Cells as Carriers for Drugs. A Method for Disseminating Chemotherapeutics, Hormones, Enzymes and Other Therapeutic Agents via the Circulatory System, DeLoach and Sprangel, eds., First International Conference on Red Blood Cell Carriers at the Rockefeller Foundation Bellagio Study and Conference Center, Bellagio (Italy), Feb. 27-Mar. 2, 1984, Karger, Basel, pp. 82-91.
Schlegel, 1985, "Red cell-mediated microinjection of antibodies," in Red Blood Cells as Carriers for Drugs. A Method for Disseminating Chemotherapeutics, Hormones, Enzymes, and Other Therapeutic Agents via the Circulatory System, DeLoach and Sprangel,
Hill Jr. Robert J.
The Research Foundation of the State University of New York
Wang Gian P.
LandOfFree
Method for preparing targeted carrier erythrocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing targeted carrier erythrocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing targeted carrier erythrocytes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-395876